St. Luke’s Sleep Medicine and Research Center is now enrolling participants in a clinical study to evaluate the safety and effectiveness of the Apnex Hypoglossal Nerve Stimulation (HGNS) System, an implantable device, to treat obstructive sleep apnea (OSA).

Continuous positive airway pressure (CPAP), which involves a pressurized mask over the nose, is considered the ‘gold standard’ for the treatment of sleep apnea, but many people have difficulty tolerating it,” said Paula Schweitzer, PhD, St. Luke’s Sleep Medicine and Research Center director of research. “This implantable device offers a new approach for those who have not had success with CPAP or other sleep apnea treatments.”

People interested in learning if they qualify for the Apnex Clinical Study may call 888-975-3370 begin_of_the_skype_highlighting            888-975-3370     end_of_the_skype_highlighting or visit stlukes-stl.com/sleep. Qualified participants will receive the medical device and care free of charge.

Related Posts with Thumbnails

Tagged with:

Filed under: Clinical TrialsCPAPCPAP DeviceCPAP TherapyObstructive Sleep ApneaSleep ApneaSleep Apnea DevicesSleep Apnea EventsSleep Apnea NewsSleep Apnea ResearchSleep Apnea Treatment

Like this post? Subscribe to my RSS feed and get loads more!